Apellis Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of APLS for the last quarter is 196.83 M USD, and it's 1.43% lower compared to the previous quarter. The net income of Q3 24 is -57.45 M USD.